Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Yeaji Suh, PhD, DAOM
Dr. Yeaji Suh has a PhD in East Asian Languages and Cultures from UCLA. She is licensed to practice in California, as well as Nevada, and has published numerous articles and translations. She has also served as an executive educational administrator in California and Nevada AOM institutions.